Prescription-Drugs-Pricing Congressional Hearing Question High Prices in U.S.
WASHINGTON, D.C. – The CEOs of three major drug companies faced tough questioning from the Senate Committee on Health, Education, Labor and Pensions on Thursday regarding the soaring prices of prescription drugs in the United States. Vermont Senator Bernie Sanders, the chairman of the committee, pressed the executives about the significant price disparities between the U.S. and other countries, citing specific examples of drugs being significantly more expensive in the U.S. compared to nations like …